SciSparc Net Income 2017-2024 | SPRC

SciSparc net income from 2017 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
SciSparc Annual Net Income
(Millions of US $)
2024 $-6
2023 $-5
2022 $-3
2021 $-6
2020 $-3
2019 $-5
2018 $-9
2017 $-6
2016 $-2
2015 $0
SciSparc Quarterly Net Income
(Millions of US $)
2024-06-30
2018-12-31 $-4
2018-09-30 $-2
2018-06-30 $-1
2018-03-31 $-2
2017-12-31 $-3
2017-09-30 $-1
2017-06-30 $-2
2017-03-31 $-1
2016-12-31
2016-09-30 $-1
2016-06-30 $-1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.001B
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company. It focuses on the development of therapies to treat disorders of the central nervous system. The company's product pipeline includes SCI-110, SCI-160 and SCI-210. SciSparc Ltd. is based in TEL AVIV, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.223B 30.47
Zoetis (ZTS) United States $70.824B 26.42
Takeda Pharmaceutical (TAK) Japan $49.065B 9.76
Daiichi Sankyo, - (DSNKY) Japan $43.191B 22.14
BeOne Medicines - (ONC) Cayman Islands $26.778B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.734B 0.00
Merck (MKKGY) Germany $17.176B 12.59
Summit Therapeutics (SMMT) United States $16.799B 0.00
Shionogi (SGIOY) Japan $15.040B 15.07
United Therapeutics (UTHR) United States $13.316B 11.78
Neurocrine Biosciences (NBIX) United States $12.806B 43.86
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Corcept Therapeutics (CORT) United States $7.565B 61.50
Stevanato Group S.p.A (STVN) Italy $7.414B 45.33
Ionis Pharmaceuticals (IONS) United States $6.938B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.664B 0.00
Grifols, S.A (GRFS) Spain $6.284B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.344B 0.00
Hypermarcas (HYPMY) Brazil $3.180B 20.92
Crinetics Pharmaceuticals (CRNX) United States $2.756B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.623B 14.19
Catalyst Pharmaceuticals (CPRX) United States $2.616B 9.17
NewAmsterdam Pharma (NAMS) Netherlands $2.129B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.887B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.835B 0.00
ARS Pharmaceuticals (SPRY) United States $1.645B 0.00
Endo (NDOI) United States $1.631B 0.00
Evotec AG (EVO) Germany $1.541B 0.00
Ocular Therapeutix (OCUL) United States $1.507B 0.00
Guardian Pharmacy Services (GRDN) United States $1.303B 0.00
Harrow (HROW) United States $1.121B 0.00
Dyne Therapeutics (DYN) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.013B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.012B 20.24
Ardelyx (ARDX) United States $1.002B 0.00
Verve Therapeutics (VERV) United States $0.999B 0.00
Collegium Pharmaceutical (COLL) United States $0.980B 5.29
Akebia Therapeutics (AKBA) United States $0.953B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.852B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Xeris Biopharma Holdings (XERS) United States $0.740B 0.00
Elite Pharmaceuticals (ELTP) United States $0.641B 0.00
Relay Therapeutics (RLAY) United States $0.617B 0.00
USANA Health Sciences (USNA) United States $0.604B 13.14
Xencor (XNCR) United States $0.591B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.586B 0.00
KalVista Pharmaceuticals (KALV) United States $0.586B 0.00
Bioventus (BVS) United States $0.563B 14.27
Theravance Biopharma (TBPH) United States $0.553B 0.00
Zevra Therapeutics (ZVRA) United States $0.515B 0.00
Organogenesis (ORGO) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.477B 9.97
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Tourmaline Bio (TRML) United States $0.416B 0.00
Altimmune (ALT) United States $0.397B 0.00
AleAnna (ANNA) United States $0.391B 0.00
Aquestive Therapeutics (AQST) United States $0.366B 0.00
Savara (SVRA) United States $0.363B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 9.01
Heron Therapeutics (HRTX) United States $0.328B 0.00
Nektar Therapeutics (NKTR) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.280B 25.71
Tonix Pharmaceuticals Holding (TNXP) United States $0.259B 0.00
Aldeyra Therapeutics (ALDX) United States $0.240B 0.00
Liminatus Pharma (LIMN) United States $0.229B 0.00
Esperion Therapeutics (ESPR) United States $0.228B 0.00
OmniAb (OABI) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
MediWound (MDWD) Israel $0.207B 0.00
China SXT Pharmaceuticals (SXTC) China $0.207B 0.00
4D Molecular Therapeutics (FDMT) United States $0.200B 0.00
Larimar Therapeutics (LRMR) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Journey Medical (DERM) United States $0.164B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.157B 0.00
Lexeo Therapeutics (LXEO) United States $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Galectin Therapeutics (GALT) United States $0.137B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Korro Bio (KRRO) United States $0.123B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Nutriband (NTRB) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.115B 0.00
Champions Oncology (CSBR) United States $0.107B 17.66
Protara Therapeutics (TARA) United States $0.107B 0.00
VAXART, INC (VXRT) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Achieve Life Sciences (ACHV) Canada $0.078B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.89
Gain Therapeutics (GANX) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Jupiter Neurosciences (JUNS) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.023B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Ainos (AIMD) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.11
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
ProKidney (PROK) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00